Updated:
Apex Innovative Sciences
Apex Innovative Sciences operates as an independent clinical trial site operator. It focuses on Phase I-IV studies for central nervous system indications and...
Overview
Apex Innovative Sciences operates as an independent clinical trial site operator. It focuses on Phase I-IV studies for central nervous system indications and other therapeutic areas, including neurology, psychiatry, addiction, and others. The company was founded in 2019 and is based in Garden Grove, California.
General information
Location
Region
North America
Country
United States
City
Garden Grove
Corporate office
Garden Grove, CA, United States
Frequently asked questions
Who manages Apex Innovative Sciences?
No named principals are publicly available. The firm's leadership and investment decision-makers have not been identified in any public record or professional directory.
What is Apex Innovative Sciences' investment strategy?
The firm has not publicly disclosed an investment strategy. No sector focus, asset class preferences, or deal types are known from available sources.
Does Apex Innovative Sciences have any known portfolio companies?
No portfolio companies or direct investments have been reported in public records, news media, or industry databases.
Where does the capital for Apex Innovative Sciences come from?
The source of capital is not disclosed. Wealth origin remains unknown without public filings or firm communications.
Has Apex Innovative Sciences been involved in any recent deals?
No recent investment activity, partnerships, or operational events are available in public sources from the past 24 months.
How can I contact Apex Innovative Sciences?
No public contact information, such as a website or phone number, is available. The firm is not present on LinkedIn or major business registries beyond a general location.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: